Open access
69
Views
13
CrossRef citations to date
0
Altmetric
Original Research
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry
Amber R Salter1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]
, Ruth Ann Marrie2 Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada;3 Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
, Neetu Agashivala4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Daniel A Belletti4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Edward Kim4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Gary R Cutter1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
, Stacey S Cofield1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
& Tuula Tyry5 Division of Neurology, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
show all
Pages 971-979
|
Published online: 04 Jul 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.